Nautilus Biotechnology

IPO

Unlocking the proteome to fuel a new era of scientific discovery

Public · Seattle, United States · Founded 2016 · $90.7M raised

Employees
51–200
Founded
2016
Business Model
B2B
Total Funding
$90.7M
Last Round
$14.7M Corporate RoundJul 2021
Rounds
4
Type
Public

About

Accurate single-molecule quantification of proteins and proteoforms

Summary

Nautilus Biotechnology is an Artificial Intelligence company based in Seattle, United States, founded in 2016. It has raised $90.7M in total across 4 rounds, most recently a $14.7M Corporate Round round in Jul 2021. Investors include Arya Sciences Acquisition Corp III, Vulcan Capital and Bezos Expeditions.

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Corporate RoundCorporate RoundJul 2021
$14.7M

Sign up to see all 5 rounds

Seed through Corporate Round — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Nautilus Biotechnology on Indexed.vc
<a href="https://indexed.vc/companies/nautilus-biotechnology"><img src="https://indexed.vc/api/badge/company/nautilus-biotechnology" alt="Nautilus Biotechnology on Indexed.vc" width="260" height="76" /></a>